Your browser doesn't support javascript.
loading
Outcome of patients with sarcoma and other mesenchymal tumours participating in phase I trials: a subset analysis of a European Phase I database.
Cassier, P A; Polivka, V; Judson, I; Soria, J-C; Penel, N; Marsoni, S; Verweij, J; Schellens, J H; Morales-Barrera, R; Schöffski, P; Voest, E E; Gomez-Roca, C; Evans, T R J; Plummer, R; Gallerani, E; Kaye, S B; Olmos, D.
Afiliação
  • Cassier PA; Drug Development Unit, The Royal Marsden National Health Service Foundation Trust, Sutton The Institute of Cancer Research, Sutton, UK Departments of Medical Oncology cassierp@hotmail.com.
  • Polivka V; Biostatistics, Centre Léon Bérard, Lyon.
  • Judson I; Drug Development Unit, The Royal Marsden National Health Service Foundation Trust, Sutton The Institute of Cancer Research, Sutton, UK.
  • Soria JC; Department of Medicine, Institut Gustave Roussy, Villejuif.
  • Penel N; Department of General Cancer, Centre Oscar Lambret, Lille, France.
  • Marsoni S; Southern Europe New Drug Organization Foundation, Milan, Italy.
  • Verweij J; Erasmus University Medical Center, Cancer Institute, Rotterdam.
  • Schellens JH; The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Morales-Barrera R; Research Unit for Molecular Therapy of Cancer, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Schöffski P; Department of General Medical Oncology, University Hospitals Leuven, Leuven Laboratory of Experimental Oncology, KU Leuven, Leuven, Belgium.
  • Voest EE; University Medical Center Utrecht, Utrecht, The Netherlands.
  • Gomez-Roca C; Department of Medicine, Institut Gustave Roussy, Villejuif.
  • Evans TR; The Beatson West of UK Cancer Centre, Glasgow.
  • Plummer R; Northern Centre for Cancer Care, Freeman Hospital, Newcastle upon Tyne, UK.
  • Gallerani E; Department of Oncology, Istituto Oncologico Della Svizzera Italiana, Bellinzona, Switzerland.
  • Kaye SB; Drug Development Unit, The Royal Marsden National Health Service Foundation Trust, Sutton The Institute of Cancer Research, Sutton, UK.
  • Olmos D; Drug Development Unit, The Royal Marsden National Health Service Foundation Trust, Sutton The Institute of Cancer Research, Sutton, UK.
Ann Oncol ; 25(6): 1222-8, 2014 Jun.
Article em En | MEDLINE | ID: mdl-24608201
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma / Ensaios Clínicos Fase I como Assunto Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma / Ensaios Clínicos Fase I como Assunto Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2014 Tipo de documento: Article